Health
Obesity drug trial: One third of participants lose 20 per cent of body weight – The New Daily
US researchers are trumpeting a new drug as a “game changer” in the management of obesity – and for once, a large, gold-standard clinical trial backs up the hype….
US researchers are trumpeting a new drug as a “game changer” in the management of obesity and for once, a large, gold-standard clinical trial backs up the hype.
A single weekly injection of the drug semaglutide, for 68 weeks, saw an average loss of 15 percent body weight in trial participants.
Those given a placebo, in tandem with a diet and exercise program, lost 2.4 per cent of their body weight.
More than a third of the participants who took the drug lost more than 20 percent of their weight.
…
-
Business22 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News16 hours agoTwo trapped and fighting for life after major three-vehicle crash in Brisbane
-
Noosa News24 hours agoNick Cave and The Bad Seeds Are Bringing Their ‘Wild God’ Tour to Australia and New Zealand in 2026
-
Business23 hours agoWhat’s Bell Potter’s take on Endeavour Group shares following earnings results?